$ino possible pennant pattern. Going to move up or down soon. i see a pennant pattern. what do you see?
0A43 trade ideas
Inovio Pharmaceuticals - Potential BuyBull flag - wait for correction and buy, pay close attention to the volume. Only buy if volume increases at time of breakout or it is probably a fakeout.
Higher volume - buy on retest
Low volume - leave
I Won't Give in to FOMO.....I Won't Give in to FOMO LOLSaw this one, got too high, so I watched it. I was fighting FOMO the entire time, now it's back down. The market is too choppy today. I am going to sit out today. Good luck out there guys. One day the bulls will run again.
INO Bullish Trend (03/11/2020)Simply: Bullish Trend.
If the stock movement breaks the blue line (resistance), the stock will goes up super fast, expecting +15%.
F* it I already missed a good entryCorona will spread even further, economy is effected hard and this is just even the beginning, every body will pump the fresh printed central bank money in companys like inovio, ibio... (almost everything with pharmaceuticals in their name :D) just mentioning the gates foundation
maybe the beginning of the end #gloomanddoom, take profits as soon as your trade is satisfying enough for you, dont be greedy, get the shit out and buy physical gold and silver see you after apoc hf gl
Inovio Pharmaceuticals, Inc. Bullish Signal $inoInovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
INO/USD BOUNCE ZONE? LONG TERM MTFA ENGLISHHello traders,
I tried to make the chart clear, hopefully it does I expect, which is to retrace for a 3 before reversing. All of this depends on the current state of containment with COVID-19 in the US.
-Live long and profit.
zm
Inovio Pharmaceuticals, Inc. trade Ideas $inoShort interest 13.35%
Company Profile
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
INO: lost opportunity, not the first and not the last one.Crazy bull run from INO, which was missed and partially screwed up.. I realized some profit, but well below my target.
Entered the market at 4.28 and jumped out at 5.13, while my target was around 8.45..
I should have followed the initial plan, i should't have jumped out, i could realize more.. now i would do this, i would do that, blablabla...
It's easy to speak and difficult to act.
This is one of the lessons that I got during my trading career and which I want to share: "shoulda, coulda, woulda" obviously doesn't work.
I believe there are still plenty of them waiting out there, so everyday is a lost opportunity, but at the same it's just another one to focus on.
Move on and concentrate on what you have instead of what you don't.
//
I want to thank you guys (and of course my future wife) for all of the support you gave me during this 2 month, it helps me to improve and motivates me to do what i am doing here.
$INO Maybe one more to 24.37, but RR is worth a shorteasy, stop-loss the local top and aim for the circles.
Tutorial- Don't think like the herd......Ask yourself, what would the herd think like base on the information presented to you. Learn to recognize clickbaits and emotional attachments to the info...
INO has seen major gains due to virus outbreakInovio Pharmaceuticals has skyrocketed amid reports it may be developing a vaccine for the Coronavirus.
There's no patterns that can really be drawn on this chart, it's so vertical. The RSI says conditions are overbought, as to be expected, but the rally can easily continue after some profit-taking. Buyers still outweigh sellers in terms of volume.
Event driven rally will take $INO to new hights$INO ceo told #POTUS Donald Trump they will will start testing a new #coronavirus vaccine on humans in China and Korea next month
Companies that hadhad weaker announcements like moderna had a huge rally last week
Buy it now
New 52 week high is coming
INO Broadening Wedge | Coronavirus Vaccine?Evening traders!
Today’s update will be on INO, trading in a descending broadening wedge which serves as a bullish pattern.
Points to consider
- Trend trading in a lower high projection
- Broke 21 week MA (S/R Flip)
- Structural weekly resistance
- RSI resting on support
- Stochastics neutral
- Clean volume influx
INO is trading in a bear trend putting in consecutive lower highs in a macro broadening wedge. The 21 weekly EMA has broken and confirmed as recent support within the larger formation.
Macro weekly structural resistance is a key level to close above; INO will be extremely bullish if this comes to fruition.
The RSI is currently resting on its support; a break below will increase bearish bias and INO being rejected from current resistance.
Clean volume climaxes are evident; this is probably due to fundamentals as the company is trying to formulate a vaccine for the corona virus.
Overall, in my opinion, from a technical stand point, this is a classic descending broadening wedge. A close above weekly structural resistance will increase the likely hood of INO meeting the technical target.
What are your thoughts?
Please leave a like and comment,
And psychologically,
“Remember that stocks are never too high for you to begin buying or too low to begin selling.”
Inovio Pharmaceutical Inc TargetsInovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
